Creatine for amyotrophic lateral sclerosis
Creatine for amyotrophic lateral sclerosis is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
"Creatine for Amyotrophic Lateral Sclerosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457103/all/Creatine_for_amyotrophic_lateral_sclerosis.
Creatine for amyotrophic lateral sclerosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457103/all/Creatine_for_amyotrophic_lateral_sclerosis. Accessed April 1, 2023.
Creatine for amyotrophic lateral sclerosis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457103/all/Creatine_for_amyotrophic_lateral_sclerosis
Creatine for Amyotrophic Lateral Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 April 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457103/all/Creatine_for_amyotrophic_lateral_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Creatine for amyotrophic lateral sclerosis ID - 457103 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457103/all/Creatine_for_amyotrophic_lateral_sclerosis PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -